# Niki BioSolutions, Inc. Common Stock (NIKI)

> Niki BioSolutions, Inc. Common Stock (NIKI) trades at $1.57 (-6.55%) as of 6:48:48 PM EST on Nov 20, 2026, -15.59% over the past month. Market cap is $1.28M, with 1.0 days to cover in short interest.

Canonical: https://massive.com/quote/niki
Data as of: 2026-11-20T23:48:48.523Z (15-minute delayed)
Source: Massive (https://massive.com/docs/llms.txt)

## Price

**$1.57** -0.11 (-6.55%)
At close · 15-minute delayed
Nasdaq · usd

After hours: **$1.50** -0.07 (-4.46%)
As of 6:48:48 PM EST on Nov 20, 2026 · After hours

## Stock performance

How Niki BioSolutions, Inc. Common Stock (NIKI) stock has performed from one day to one year, with its 52-week range.

| Period | Return |
| --- | --- |
| 1D | -6.55% |
| 1W | -4.85% |
| 1M | -15.59% |
| YTD | -82.22% |
| 1Y | -82.22% |
| 52-wk range | $1.42 – $12.24 |

From daily closes through Nov 20, 2026.

## Key statistics

Today's trading snapshot for NIKI: day range, open, previous close, volume and market cap.

| Measure | Value |
| --- | --- |
| Day range | $1.52 – $1.62 |
| Open | $1.57 |
| Prev close | $1.68 |
| Volume | 6.7K |
| Market cap | $1.28M |
| Shares out | 814.38K |

## Insider trading

[Niki BioSolutions, Inc. Common Stock (NIKI) insider trading](https://massive.com/quote/niki/insider-trading.md): open-market Form 4 buys and sells by Niki BioSolutions, Inc. Common Stock insiders over the last 12 months.

## 8-K filings

Material corporate events Niki BioSolutions, Inc. Common Stock has disclosed to the SEC on Form 8-K.

- Oct 13, 2026 · Cfo appointment
  “On October 9, 2026, the Board of Directors (the "Board") of Niki BioSolutions, Inc. ... appointed Thomas Freeburg as the Chief Financial Officer, to serve at the discretion of the Board, for a period of two years, commencing as of September 1, 2026, unless terminated sooner by either party.”
- Oct 9, 2026 · Underwriting agreement
  “On October 9, 2026, Niki BioSolutions, Inc. entered into an At the Market Offering Agreement with H.C. Wainwright & Co., LLC and Brookline Capital Markets. The Sales Agreement provides for the sale and issuance of the Company's common stock from time to time through or to Wainwright as sales agent and/or principal.”
- Sep 14, 2026 · Investor presentation
  “We are filing this report to disclose our corporate PowerPoint presentation. The presentation is furnished as an exhibit to this Current Report on Form 8-K.”
- Sep 4, 2026 · Equity compensation grant
  “Mr. Mireskandari ... was granted 20,000 restricted stock units (RSUs) vesting immediately at the closing of the merger transaction and options to purchase 800,000 shares of the Company's common stock under the Company's 2026 Equity Incentive Plan, subject to the vesting conditions set forth in the Mireskandari Employment Agreement.”
- Aug 21, 2026 · [Merger completion](https://massive.com/quote/sec-filings/8-k/mergers.md)
  “on that same day (the "Closing Date"), after obtaining the requisite shareholder approval and satisfying the closing conditions, Niki BioSolutions, Inc. (formerly known as Aptorum Group Limited, a Cayman Islands exempted company with limited liability ("Aptorum")) (the "Company") consummated its previously announced merger (the "Closing") pursuant to that certain Agreement and Plan of Merger on July 14, 2025, (the "Merger Agreement"), between Aptorum and DiamiR Biosciences Corp., a Delaware corporation ("DiamiR"), pursuant to which, among other matters, Aptorum was to form a direct, wholly owned subsidiary in the state of Delaware ("Merger Sub"). On July 20, 2026, immediately following the Domestication, Merger Sub merged with and into DiamiR in accordance with the applicable provisions of the DGCL, with DiamiR continuing as the surviving company and a wholly-owned subsidiary of Aptorum (the "Merger").”

## NIKI short interest

How heavily NIKI is shorted: shares short, days to cover and average daily volume.

| Measure | Value |
| --- | --- |
| Days to cover | 1.0 |
| Short interest | 1.72K |
| Avg volume | 11.97K |

As of Oct 30, 2026 · reported to FINRA twice monthly.

## About Niki BioSolutions, Inc. Common Stock

Niki BioSolutions Inc is a clinical-stage life sciences company focused on unmet medical needs and providing genomic and biomarker testing solutions to healthcare providers, research institutions, and life sciences organizations. Its activities include the development and application of proprietary technologies to support precision medicine across therapeutic areas including brain health and oncology. The company also collaborates with academic centers, disease foundations, and biopharmaceutical companies.

| Measure | Value |
| --- | --- |
| Exchange | Nasdaq |
| Market | stocks |
| Type | CS |
| Currency | USD |
| Employees | 2 |
| Listed | Dec 18, 2018 |

[Company website](https://www.aptorumgroup.com)

## FAQ

### What is the Niki BioSolutions, Inc. Common Stock (NIKI) stock price today?

Niki BioSolutions, Inc. Common Stock (NIKI) is trading at $1.57 (-6.55% on the day) as of 6:48:48 PM EST on Nov 20, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.

### What is Niki BioSolutions, Inc. Common Stock?

Niki BioSolutions Inc is a clinical-stage life sciences company focused on unmet medical needs and providing genomic and biomarker testing solutions to healthcare providers, research institutions, and life sciences organizations.

### What is the short interest in NIKI?

As of Oct 30, 2026, NIKI has 1.72K shares short and 1.0 days to cover.

### What exchange is NIKI listed on?

Niki BioSolutions, Inc. Common Stock (NIKI) trades on Nasdaq in USD.

## Live data

Prices here are 15-minute delayed. For real-time NIKI quotes and the full history behind this page, use the Massive API or MCP server:

- `GET https://api.massive.com/v3/snapshot?ticker.any_of=NIKI`

Requests need a Massive API key. API reference for agents: https://massive.com/docs/llms.txt. Connect an AI agent through the Massive MCP server: https://massive.com/docs/ai-tools.

## Related

- [Niki BioSolutions, Inc. Common Stock (NIKI) insider trading](https://massive.com/quote/niki/insider-trading.md)
- [SEC 8-K events](https://massive.com/quote/sec-filings/8-k.md)
- [Markets overview](https://massive.com/quote/index.md)

Nothing here is investment advice. Data and content are provided for informational purposes under the Massive Terms of Service: https://massive.com/terms
